专家文章 | 方维佳

搜索
登录

热心肠智库专家文章 | 方维佳

2024

CAA case of dMMR/MSI-H/TMB-H colon cancer with brain metastasis treated with PD-1 monoclonal antibody

Zhejiang da xue xue bao. Yi xue ban, 10.3724/zdxbyxb-2023-0547

2023

CADevelopment of a whole-slide-level segmentation-based dMMR/pMMR deep learning detector for colorectal cancer

iScience, 10.1016/j.isci.2023.108468

CAAn immunometabolism subtyping system identifies S100A9+ macrophage as an immune therapeutic target in colorectal cancer based on multiomics analysis

CELL REP MED, 10.1016/j.xcrm.2023.100987

点击查看热心肠日报解读

2022

FAA Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

CLIN CANCER RES, 10.1158/1078-0432.CCR-22-0655

CAAdvances in CAR-T cell therapy for malignant solid tumors

Zhejiang da xue xue bao. Yi xue ban, 10.3724/zdxbyxb-2022-0044

CACharacterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value

Front Cell Dev Biol, 10.3389/fcell.2021.760618

CASingle-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy

J IMMUNOTHER CANCER, 10.1136/jitc-2021-003133

2021

CAInterleukin-33 as an early predictor of cetuximab treatment efficacy in patients with colorectal cancer

Cancer Med, 10.1002/cam4.4331

CAEmerging treatment evolutions and integrated molecular characteristics of biliary tract cancers

Cancer Sci, 10.1111/cas.15139

CASignaling pathway perturbation analysis for assessment of biological impact of cigarette smoke on lung cells

Sci Rep, 10.1038/s41598-021-95938-z

CADepiction of the genomic and genetic landscape identifies CCL5 as a protective factor in colorectal neuroendocrine carcinoma

BJC, 10.1038/s41416-021-01501-y

CAImmunotherapy for targeting cancer stem cells in hepatocellular carcinoma

THERANOSTICS, 10.7150/thno.54648

2020

CAAnalysis of the molecular nature associated with microsatellite status in colon cancer identifies clinical implications for immunotherapy

J IMMUNOTHER CANCER, 10.1136/jitc-2020-001437

CAIntegrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC

CANCER IMMUNOL IMMUN, 10.1007/s00262-020-02669-7

CASCAU-Net: Spatial-Channel Attention U-Net for Gland Segmentation

FRONT BIOENG BIOTECH, 10.3389/fbioe.2020.00670

CAUltra-stable Biomembrane Force Probe for Accurately Determining Slow Dissociation Kinetics of PD-1 Blockade Antibodies on Single Living Cells

NANO LETT, 10.1021/acs.nanolett.0c01360

CAAnti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review

Front Immunol, 10.3389/fimmu.2020.01037

CADynamic alterations of genome and transcriptome in KRAS G13D mutant CRC PDX model treated with cetuximab

BMC CANCER, 10.1186/s12885-020-06909-y

CANutrition and metabolism status alteration in advanced hepatocellular carcinoma patients treated with anti-PD-1 immunotherapy

SUPPORT CARE CANCER, 10.1007/s00520-020-05478-x

2019

CAGut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma

J IMMUNOTHER CANCER, 10.1186/s40425-019-0650-9

点击查看热心肠日报解读